At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 45 enrolled
Drug / intervention
COPA AMD (note: name is not an acronym) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing
In Brief
A Phase 2 clinical trial evaluating COPA AMD (note: name is not an acronym) and COPA (note: name is not an acronym) for Wounds. Completed, enrolled 45 participants across 2 sites.
Detailed Summary
This is a multi-center, prospective, randomized, double blind, pilot clinical trial of subjects with chronic wounds. The purpose of this study is to compare the efficacy of COPA AMD PHMB Impregnated foam dressing compared to regular foam dressing in subjects with chronic wounds.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWounds
CountriesCanada
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionApr 2009
TodayJul 2026
First PostedFeb 20, 2008
Enrollment StartFeb 1, 2008
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 18.4 years ago
Interventions
COPA AMD (note: name is not an acronym)device
Foam dressing impregnated with Polyhexamethylene Biguanide
COPA (note: name is not an acronym)device
Regular foam dressing without PHMB